TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/1/22 19:29 | 11/29/22 | NRXP | Nrx Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Javitt Daniel C. | DE | T | S.m | -33 | 1.50 | 0 | -22 | 0 | 9,635 | I | |||||||||||||||
11/18/22 19:05 | 11/16/22 | NRXP | Nrx Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Javitt Daniel C. | DE | T | S.m | -171 | 1.03 | 0 | -167 | -2 | 9,657 | I | |||||||||||||||
11/15/22 19:40 | 11/11/22 | NRXP | Nrx Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Javitt Daniel C. | DE | T | S | -50 | 1.01 | 0 | -49 | 0 | 9,824 | I | |||||||||||||||
8/2/22 17:43 | 7/29/22 | NRXP | Nrx Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Javitt Daniel C. | DE | T | S | -791 | 1.01 | 0 | -784 | -7 | 9,873 | I | |||||||||||||||
6/7/22 20:11 | 6/3/22 | NRXP | Nrx Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Javitt Daniel C. | DE | T | S.m | -304 | 0.6819 | 0 | -446 | -3 | 12,657 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |